Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Remala Abadi Tbk. (DATA) vs Merck Tbk. (MERK) Price & Performance

Remala Abadi Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Remala Abadi Tbk. vs Merck Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp2,450 (market cap 3.29T, 15.47M 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Remala Abadi Tbk. is the larger of the two by market cap, and Remala Abadi Tbk. is more actively traded (15.47M versus 33.3K). Which is the better fit depends on your goals.

DATAMERK
Market Cap
3.29T1.68T
Volume
15.47M33.3K
Lot
154.74K333
Turnover
37.99B126.46M
Average Price
2,454.893,797.72
Value
37.99B126.46M
Indicative Equilibrium Price
2,4503,800
Indicative Equilibrium Volume
2.17K9

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DATA
View details
MERK
View details

About Remala Abadi Tbk.

PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.

Read more on DATA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK